Aselacin A
Aselacin A targets endothelin-1 receptor (ET-1 receptor), inhibits the the binding of ET-1 to ETA receptor and ETB receptor. Aselacin A inhibits the ET-1 binding to bovine atrial membrane and porcine cerebral membrane with IC50 of 22 μg/mL and 20 μg/mL. Aselacin A can be used for research of cardiovascular diseases[1].
Product Specifications
CAS Number
156223-06-2
UNSPSC
12352005
Target
Endothelin Receptor
Related Pathways
GPCR/G Protein
Field of Research
Cardiovascular Disease
Smiles
O=C1O[C@@H]([C@@H](C(NCCC(N[C@H](CC2=CNC3=C2C=CC=C3)C(N[C@H](CO)C(NC1)=O)=O)=O)=O)NC([C@@H](CCC(N)=O)NC(CCCCCCCC(/C=C/C=C/CCCCC)O)=O)=O)C
Molecular Formula
C46H68N8O11
Molecular Weight
909.08
References & Citations
[1]Jackson M, et al., Aselacins, novel compounds that inhibit binding of endothelin to its receptor. I. The producing organism, fermentation and biological activity. J Antibiot (Tokyo) . 1994 May;47 (5) :523-7.
Shipping Conditions
Room temperature
Scientific Category
Natural Products
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Cr8247-500gEcoli 500 µg (E. coli)
Recombinant Streptococcus Salivarius ptsH Protein (aa 1-87)
Sign In for Pricing
View Details 
033858-APC 200 µL
CHN2, ID (CHN2, ARHGAP3, BCH, Beta-chimaerin, Beta-chimerin, Rho GTPase-activating protein 3) (APC) discontinued
Sign In for Pricing
View Details A00956Y260 100 µL
Anti-Sodium Potassium ATPase alpha-1 ATP1A1 Antibody (Phospho-Tyr260)
Sign In for Pricing
View Details